Clinical Research Directory

Inclusion Criteria: * Patient to be treated with DERIVO® 2heal® Embolisation Device due to intracranial aneurysm according to IFU * Age \> 18 years * Signed Informed Consent Form * Patient scheduled to be treated for only one target aneurysm except multiple aneurysms located in the same target zone to be treated with one DERIVO® 2heal® Embolisation Device * Effective use of antiplatelet medication confirmed by applicable testing method according to local standard Exclusion Criteria: * Previously treated aneurysms with flow diverter, stent or WEB device * Treatment as preparation for the flow-diversion treatment does not lead to exclusion of the patient * Patient with a ruptured aneurysm in the acute phase of bleeding * Pre-treatment disability (mRS \> 2) * Aneurysms related to pre-existing arteriosclerotic vascular disease in the target vessel * Contraindication against treatment with anti-platelet medication * Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study * Participating in another study